Advertisement
Advertisement
Vastarel MR

Vastarel MR

trimetazidine

Manufacturer:

Servier

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Trimetazidine diHCl
Indications/Uses
Add-on therapy for symptomatic treatment in adults w/ stable angina pectoris who are inadequately controlled by or intolerant to 1st-line anti-anginal therapies.
Dosage/Direction for Use
1 tab bd. Moderate renal impairment (CrCl 30-60 mL/min) 1 tab in the morning.
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Parkinson's disease, parkinsonian symptoms, tremors, restless leg syndrome & other related movement disorders. Severe renal impairment (CrCl <30 mL/min).
Special Precautions
Discontinue use if signs & symptoms of severe cutaneous adverse reactions; movement disorders eg, parkinsonian symptoms, restless leg syndrome, tremors, postural instability occur. Not a curative treatment for angina attacks or as initial treatment for unstable angina, MI, pre-hospital phase or during 1st days of hospitalisation. Falls related to postural instability or hypotension. Positive results in anti-doping tests. May affect ability to drive & use machines. Moderate renal impairment. Avoid use during pregnancy. Not to be used during lactation. Childn <18 yr. Elderly >75 yr.
Adverse Reactions
Dizziness, headache; abdominal pain, diarrhoea, dyspepsia, nausea, vomiting; rash, pruritus, urticaria; asthenia.
MIMS Class
Anti-Anginal Drugs
ATC Classification
C01EB15 - trimetazidine ; Belongs to the class of other cardiac preparations.
Presentation/Packing
Form
Vastarel MR MR-FC tab 35 mg
Packing/Price
60's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement